FLGT CSO Sells $39K in Stock to Cover Taxes on Vested RSUs
Fulgent Genetics, Inc.
Subscribe to track FLGT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
FLGT CSO Sells $39K in Stock to Cover Taxes on Vested RSUs
Company: Fulgent Genetics, Inc. (FLGT) Form: 4 | Filed: 2025-10-28 Significance: Low
Insider: Gao Hanlin Title: Chief Scientific Officer | Relationship: Officer
Transaction: • Type: Tax Withholding • Shares: 1,642 • Price: $23.74 • Value: $38,981 • Owned After: 955,443
Key Insight: This was a non-discretionary sale (Code 'F') to cover tax obligations from vesting RSUs, not a change in the insider's outlook. The CSO retains a significant stake of over 955k shares.
Market Context: The transaction represents a negligible 0.005% of the company's $0.71B market cap, indicating it is immaterial to the market.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Fulgent Genetics, Inc. (FLGT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Scientific Officer executed a routine, non-discretionary sale of stock solely to cover tax liabilities on vesting Restricted Stock Units (RSUs).
- Market Impact: Negligible. This type of transaction does not signal a change in insider sentiment and is too small to affect the market.
Company Information
| Field | Value |
|---|---|
| Company | Fulgent Genetics, Inc. |
| Ticker Symbol | FLGT |
| CIK | 0001674930 |
| Industry | SERVICES-MEDICAL LABORATORIES |
Insider Information
| Field | Value |
|---|---|
| Name | Gao Hanlin |
| CIK | 0001684532 |
| Title/Position | Chief Scientific Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-26 |
| Transaction Code | F - Withholding of securities to satisfy tax liabilities |
| Security Type | Common Stock |
| Shares Involved | 1,642 |
| Price Per Share | $23.74 |
| Total Value | $38,980.68 |
| Shares Owned After | 955,443 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $38,980.68 |
| % of Market Cap | 0.0055% |
| Shares Transacted | 1,642 |
| % of Shares Outstanding | 0.0054% |
| Post-Transaction Ownership | 955,443 shares (3.12% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of ~$39k is an insignificant fraction of Fulgent Genetics' $710 million market capitalization.
- Ownership Concentration: The sale is minor compared to the insider's remaining holdings. The CSO still owns over 3.1% of the company's total shares outstanding, a substantial position indicating continued alignment with shareholder interests.
- Dilution Impact: Not applicable, as this was a disposition of already-owned shares, not an issuance of new equity.
- Transaction Significance: The transaction is classified as having low significance. Both its value relative to market cap and the number of shares relative to shares outstanding fall well below the lowest materiality thresholds. The nature of the transaction (tax withholding) further reduces its informational value.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The market typically ignores 'F' code transactions as they are automated, non-discretionary, and do not reflect an insider's investment decision or sentiment about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is too small to have a noticeable effect on trading volume.
- Sentiment Indicator: Neutral. This filing provides no new information to influence bullish or bearish sentiment.
Investment Insights
Positive Market Indicators
- The insider maintains a significant ownership stake of over 3% in the company post-transaction.
Risk Factors
- No risk factors are indicated by this filing.
Key Takeaways
- Routine Transaction: This is a standard "sell-to-cover" transaction to handle tax obligations from equity compensation.
- No Change in Sentiment: The sale should not be interpreted as the insider losing confidence in the company.
- Immaterial Size: The transaction's value and share count are negligible compared to the company's market cap and total shares, making it a non-event for investors.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnote explicitly states the shares were withheld to satisfy tax withholding obligations that arose upon the vesting of restricted stock units. This confirms the non-discretionary nature of the disposition.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
